Published in Cancer Chemother Pharmacol on January 01, 1987
Chemotherapy exposure increases leukemia cell stiffness. Blood (2006) 1.57
siRNA-based targeting of antiapoptotic genes can reverse chemoresistance in P-glycoprotein expressing chondrosarcoma cells. Mol Cancer (2009) 1.30
Co-variation of glutathione transferase expression and cytostatic drug resistance in HeLa cells: establishment of class Mu glutathione transferase M3-3 as the dominating isoenzyme. Biochem J (1994) 0.88
The antiapoptotic gene survivin is highly expressed in human chondrosarcoma and promotes drug resistance in chondrosarcoma cells in vitro. BMC Cancer (2011) 0.87
In vitro anthracycline cross-resistance pattern in childhood acute lymphoblastic leukaemia. Br J Cancer (1995) 0.78
Morphine enhances doxorubicin-induced cardiotoxicity in the rat. Cardiovasc Toxicol (2014) 0.75
A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V. J Immunol Methods (1995) 16.00
Flow cytometry of apoptotic cell death. J Immunol Methods (2000) 2.30
Dose intensity of MOPP chemotherapy and survival in Hodgkin's disease. J Clin Oncol (1989) 2.12
Dissociation of plasma adrenocorticotropin and cortisol levels in critically ill patients: possible role of endothelin and atrial natriuretic hormone. J Clin Endocrinol Metab (1995) 2.03
Genetic complementation analysis of ataxia telangiectasia and Nijmegen breakage syndrome: a survey of 50 patients. Cytogenet Cell Genet (1988) 1.88
Relative eosinophilia and functional adrenal insufficiency in critically ill patients. Lancet (1999) 1.63
Frequency of moles as a key to melanoma incidence? J Am Acad Dermatol (1986) 1.50
Prolonged exposure to cytosine arabinoside in the presence of hematopoietic growth factors preferentially kills leukemic versus normal clonogenic cells. Exp Hematol (1991) 1.41
Clinical course in 28 unselected patients with aplastic anaemia treated with anabolic steroids. Br J Haematol (1979) 1.39
Phase I and pharmacokinetic studies with the pentacyclic pyrroloquinone mitoquidone. Cancer Chemother Pharmacol (1988) 1.38
Clinical pharmacokinetics of doxorubicin. Clin Pharmacokinet (1988) 1.37
Macrophage migration inhibitory factor and hypothalamo-pituitary-adrenal function during critical illness. J Clin Endocrinol Metab (2001) 1.18
Preferential expression of a high number of ATP binding cassette transporters in both normal and leukemic CD34+CD38- cells. Leukemia (2006) 1.17
In addition to von Willebrand factor and urinary albumin excretion, plasma endothelin is an indicator of endothelial dysfunction in diabetes mellitus. Diabetologia (1993) 1.09
Weekly treatment of psoriasis with a hydrocolloid dressing in combination with triamcinolone acetonide. A controlled comparative study. Acta Derm Venereol (1994) 1.09
A method for quantification of peripheral blood admixture in bone marrow aspirates. Exp Hematol (1980) 1.09
Psoriasis of the nails associated with disability in a large number of patients: results of a recent interview with 1,728 patients. Dermatology (1996) 1.07
Apoptosis and programmed cell death in health and disease. Adv Clin Chem (1994) 1.04
Clinical course and survival in 16 patients with localized plasmacytoma. Scand J Haematol (1984) 1.02
Apoptotic cell death kinetics in vitro depend on the cell types and the inducers used. Apoptosis (2004) 1.01
A randomized prospective study of ceftazidime versus ceftazidime plus flucloxacillin in the empiric treatment of febrile episodes in severely neutropenic patients. Antimicrob Agents Chemother (1985) 1.01
Ratiometric measurement of intracellular pH in cultured human keratinocytes using carboxy-SNARF-1 and flow cytometry. Cytometry (1991) 0.98
Adolescent and adult acute lymphoblastic leukemia: prognostic features and outcome of therapy. A study of 293 patients. Blood (1982) 0.98
The effect of lithium on platelet aggregation and platelet release reaction. Thromb Res (1977) 0.96
Hageman factor, a novel sialoglycoprotein with esterase activity. Biochim Biophys Acta (1965) 0.96
Flow cytometric analysis of epidermal subpopulations from normal and psoriatic skin using monoclonal antibodies against intermediate filaments. Am J Pathol (1989) 0.95
Flow cytometric investigations of corneocytes from psoriatic scales and the effects of Ingram therapy. J Dermatol (1986) 0.95
Antisense BCR-ABL oligonucleotides induce apoptosis in the Philadelphia chromosome-positive cell line BV173. Leukemia (1994) 0.95
Early features of apoptosis detected by four different flow cytometry assays. Apoptosis (1998) 0.94
A simple test for measuring platelet aggregation. Results in von Willebrand's disease and uraemia. Thromb Diath Haemorrh (1969) 0.94
Cell cycle kinetics in malignant lymphoma studied with in vivo iododeoxyuridine administration, nuclear Ki-67 staining, and flow cytometry. Blood (1992) 0.92
Mitochondrial biogenesis and mitochondrial activity during the progression of the cell cycle of human leukemic cells. Exp Cell Res (1988) 0.91
The immunoglobulins in Hodgkin's disease. Eur J Cancer (1976) 0.91
Pharmacokinetics of cytosine arabinoside in acute myeloid leukemia. Clin Pharmacol Ther (1977) 0.91
Apoptosis: molecular mechanisms and implications for cancer chemotherapy. Pharm World Sci (1997) 0.91
Treatment of acute lymphoblastic leukemia in adolescents and a-dults: A retrospective study of 41 patients (1970-1973). Blood (1975) 0.90
Flow cytometry as a tool for the study of cell kinetics in skin 2. Cell kinetic data in psoriasis. Br J Dermatol (1981) 0.90
Leukemic cell and plasma daunomycin concentrations after bolus injection and 72 h infusion. Cancer Chemother Pharmacol (1987) 0.90
Clinical course and survival after elective splenectomy in 19 patients with primary myelofibrosis. Br J Haematol (1977) 0.89
Three-year registry data on biological treatment for psoriasis: the influence of patient characteristics on treatment outcome. Br J Dermatol (2008) 0.89
Familial thrombopathic thrombocytopenia. Br J Haematol (1968) 0.88
Monocyte purification with counterflow centrifugation monitored by continuous flow cytometry. J Immunol Methods (1981) 0.88
Nuclear differentiation during epidermal keratinization. Arch Dermatol Res (1988) 0.88
Simultaneous measurement of DNA content and cell-surface immunofluorescence of human bone marrow cells using a single laser flow cytometer. Cytometry (1990) 0.88
Apoptosis and secondary necrosis of lymphocytes in culture. Acta Haematol (1997) 0.87
Role of allogenic bone marrow transplantation in adolescent or adult patients with acute lymphoblastic leukaemia or lymphoblastic lymphoma in first remission. Bone Marrow Transplant (1994) 0.87
Contact activation of Hageman factor and the interaction of Hageman factor and plasma thromboplastin antecedent. Thromb Diath Haemorrh (1967) 0.87
Platelet function and von Willebrand's disease. Lancet (1968) 0.86
Detection of point mutations in DNA using capillary electrophoresis in a polymer network. J Chromatogr (1993) 0.86
Flow cytometric analysis of the recruitment of G0 cells in human epidermis in vivo following tape stripping. Cell Tissue Kinet (1987) 0.85
Simplified method for DNA and protein staining of human hematopoietic cell samples. Cytometry (1981) 0.85
Blastomycosis treated successfully with miconazole. Trop Geogr Med (1979) 0.85
Cytosine arabinoside binding to human plasma proteins. Arch Int Pharmacodyn Ther (1977) 0.85
Bias in nucleotide composition of antisense oligonucleotides. Antisense Nucleic Acid Drug Dev (1996) 0.85
Apoptosis- and necrosis-inducing potential of cladribine, cytarabine, cisplatin, and 5-fluorouracil in vitro: a quantitative pharmacodynamic model. Cancer Chemother Pharmacol (1998) 0.85
Observations on platelet ultrastructure in familial thrombocytopathic thrombocytopenia. Am J Pathol (1968) 0.84
Chronic lymphocytic leukaemia presenting as renal failure with lymphocytic infiltration of the kidneys. Neth J Med (1992) 0.84
Cell kinetic characterization of growth arrest in cultured human keratinocytes. J Cell Sci (1994) 0.84
Rapid quantitative determination of four anthracyclines and their main metabolites in human nucleated haematopoietic cells. J Chromatogr (1986) 0.83
Quantitation of anthracyclines in human hematopoietic cell subpopulations by flow cytometry correlated with high pressure liquid chromatography. Cytometry (1985) 0.83
Semi-automated detection of the factor V mutation by allele specific amplification and capillary electrophoresis. Thromb Haemost (1995) 0.83
Prognostic factors in the treatment of alopecia areata with diphenylcyclopropenone. J Am Acad Dermatol (1991) 0.82
The influence of splenectomy on the invitro lymphocyte response to phytohemagglutinin and pokeweed mitogen in Hodgkin's disease. Cancer (1975) 0.82
Different susceptibilities of normal T cells and T cell lines to immunotoxins. Scand J Immunol (1988) 0.82
Cellular pharmacokinetics of daunomycin administered as continuous intravenous infusion in the treatment of acute non-lymphocytic leukaemia. Br J Haematol (1986) 0.82
Significance of fibrin split products in patients with renal failure. Scand J Haematol Suppl (1971) 0.82
Monoclonal antibodies for epidermal population analysis. J Invest Dermatol (1986) 0.82
Psoriasis treatment with etanercept and efalizumab: clinical strategies influencing treatment outcome. Br J Dermatol (2008) 0.82
Bone-marrow-profileration patterns in acute myeloblastic leukaemia determined by pulse cytophotometry. Lancet (1975) 0.81
Endogenous mediators in sepsis and septic shock. Adv Clin Chem (1998) 0.81
Preparation and clinical use of factor IX concentrate PPSB according to Soulier. Vox Sang (1969) 0.81
Autologous transplantation of bone marrow purged in vitro with anti-CD7-(WT1-) ricin A immunotoxin in T-cell lymphoblastic leukemia and lymphoma. Blood (1989) 0.81
Hormonal dependent thrombotic thrombocytopenic purpura (TTP). Scand J Haematol (1983) 0.80
Switching from etanercept to adalimumab is effective and safe: results in 30 patients with psoriasis with primary failure, secondary failure or intolerance to etanercept. Br J Dermatol (2010) 0.80
Combined immunodeficiency preceding chronic lymphocytic leukemia. Blut (1984) 0.80
First-trimester prenatal diagnosis of the Nijmegen breakage syndrome and ataxia telangiectasia using an assay of radioresistant DNA synthesis. Prenat Diagn (1990) 0.80
Bone marrow repopulation capacity after transplantation of lymphocyte-depleted allogeneic bone marrow using counterflow centrifugation. Transplantation (1984) 0.80
Cellular and plasma pharmacokinetics of weekly 20-mg 4'-epi-adriamycin bolus injection in patients with advanced breast carcinoma. Cancer Chemother Pharmacol (1986) 0.80
Effect of isotype on internalization and cytotoxicity of CD19-ricin A immunotoxins. Cancer Res (1994) 0.80
Sequential occurrence of mitochondrial and plasma membrane alterations, fluctuations in cellular Ca2+ and pH during initial and later phases of cell death. Apoptosis (1999) 0.80
"Incubation period" in Hodgkin's disease. Lancet (1975) 0.80
A hereditary abnormal c-fms proto-oncogene in a patient with acute lymphocytic leukaemia and congenital hypothyroidism. Br J Haematol (1985) 0.79
Synchronized growth in human epidermis following tape-stripping: its implication for cell kinetic studies. Cell Tissue Kinet (1988) 0.79